Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 32, Issue 2, 2005, Pages 366-372

  Bloom, Bradley J ^a,b   Nelson, Sarah M ^a   Eisenberg, Daniel ^a   Alario, Anthony J ^a  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b PFIZER INC   (United States)

Author keywords

E selectin; Endothelial activation; Intercellular adhesion molecule 1; Juvenile idiopathic arthritis

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ETANERCEPT; FIBRIN; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; VON WILLEBRAND FACTOR;

AGE; ARTICLE; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL ASSESSMENT; HUMAN; JOINT EFFUSION; JUVENILE RHEUMATOID ARTHRITIS; PARENT; PATHOGENESIS; PHYSICIAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RECORDING; SOLUBILITY;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; E-SELECTIN; ENDOTHELIUM, VASCULAR; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEALTH STATUS; HUMANS; INFANT; INTERCELLULAR ADHESION MOLECULE-1; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 13444253769     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cassidy IT, Petty RE. Textbook of pediatric rheumatology. Philadelphia: W.B. Saunders Co.; 2001.
2. Bloom BJ, Tucker LB, Miller LC, Schaller JG. Von Willebrand factor in juvenile dermatomyositis. J Rheumatol 1995;22:320-5.
3. Greaves M, Madia R, Ward A, et al. Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease. Br J Rheumatol 1987;27:281-5.
4. Woolf A, Wakerly G, Wallington T, Scott D, Dieppe P. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987;46:441-7.
5. Giustolisi R, Musso R, Cacciola E, Cacciola R, Russo M, Petralito A. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - expression of acute phase reaction or index of vascular endothelial damage? [letter]. Thromb Haemost 1984;51:408.
6. Blann AD, Farrell A, Picton A, McCollum CN. Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res 2000;97:209-16.
7. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995;90:244-8.
8. Solovey A, Gul L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 1998;101:1899-904.
9. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-97.
10. Bowyer SL, Ragsdale CG, Sullivan DB. Factor VIII related antigen and childhood rheumatic disease. J Rheumatol 1989;16:1093-7.
11. Scott JP, Gerber P, Maryjowski MC, et al. Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum 1985;28:256-61.
12. Inamo Y, Pemberton S, Tuddenham EGD, Woo P. Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis. Br J Rheumatol 1995;34:466-9.
13. Gallistl S, Mangge H, Neuwirth G, Muntean W. Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res 1998;92:267-72.
14. Bloom BJ, Tucker LB, Miller LC, Schaller JG. Fibrin d-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis. J Rheumatol 1998;25:1620-5.
15. DeBenedetti F, Pignatti P, Massa M, et al. Soluble tumor necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. Br J Rheumatol 1997;36:581-8.
16. Mussoni L, Pintucci G, Romano G, DeBenedetti F, Massa M, Martini A. Decreased fibrinolytic activity in juvenile chronic arthritis. Ann Rheum Dis 1990;49:973-5.
17. Bloom BJ, Miller LC, Tucker LB, et al. Soluble adhesion molecules in juvenile rheumatoid arthritis. J Rheumatol 1999;26:2044-8.
18. Laucella SA, Gaddi E, Balbaryski J, et al. Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases. Acta Paediatrica 1999;88:399-403.
19. DeBenedetti F, Vivarelli M, Pignatti P, et al. Circulating levels of soluble E-selectin, P-selectin, and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J Rheumatol 2000;27:2246-50.
20. Dolezalova P, Telekesova P, Nemcova D, Hoza J. Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations. Clin Exp Rheumatol 2002;20:249-54.
21. Chen CY, Tsao CH, Ou LS, et al. Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 2002;61:167-70.
22. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
23. Nash MC, Wade AM, Shah V, Dillon MJ. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (s-ICAM-1), and soluble vascular cell adhesion molecule-I (SICAM-1) decrease with age. Clin Exp Immunol 1996;103:167-70.
24. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
25. Blann AD, Herrick A, Jayson MIV. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis, and systemic sclerosis. Br J Rheumatol 1995;34:814-9.
26. Soylemezoglu O, Sultan N, Gursel T, Buyan N, Hasanoglu E. Circulating adhesion molecules ICAM-I, E-selectin, and von Willebrand factor in Henoch-Schonlein purpura. Arch Dis Child 1996;75:507-11.
27. Inward CD, Pall AA, Adu D, Milford DV, Taylor CM. Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome. Pediatr Nephrol 1995;9:574-8.
28. Blann A, Kumar P, Krupinski J, McCollum C, Beevers DG, Lip GY. Soluble intercellular adhesion molecule-I, E-selectin, vascular cell adhesion molecule-I, and von Willebrand factor in stroke. Blood Coagul Fibrinolysis 1999;10:277-84.
29. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999;48:2446-53.
30. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100:717-22.
31. Kas-Deelen AM, Harmsen MC, De Maar EF, et al. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood. Kidney Int 2000;58:2533-42.
32. Bloom BJ, Nelson SM, Alario AJ, et al. Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis. Rheumatol Int 2002;22:175-7.
33. Whitcup SM, Kozhich AT, Lobanoff M, Wolitzky BA, Chan CC. Blocking both E-selectin and P-selectin inhibits endotoxin-induced leukocyte infiltration into the eye. Clin Immunol Immmunopathol 1997;83:45-52.
34. Martin CM, Lacomba MS, Molina CI, et al. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients. Curr Eye Res 2000;20:287-92.